Editas Medicine Inc (NASDAQ:EDIT) currently has a daily average trading volume of 2.33M but it saw 9568174 shares traded in last market. With a market cap of 214.30M USD, the company’s current market price of $2.56 came rising about 13.78 while comparing to the previous closing price of $2.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.05 and as low as $0.91. In the recent trading on the day, stock has struck highest price mark of $2.235 while lowest mark touched by it was $2.875.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on April 28, 2025, recommending a price target of $3 for it.
Over the week, EDIT’s stock price is moving 16.89% up while it is 44.63% when we observe its performance for the past one month. Year-to-date it is -45.18% down and over the past year, the stock is showing an upside performance of 101.57%.
Currently, Editas Medicine Inc’s total number of outstanding shares is 83.71M with 0.33% of that held by the insiders while 57.56% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -312.51% and return on equity (ROE) at -140.82%. Stock’s beta reads 2.18. Stock has a price to book (P/B) ratio of 3.43 while price to sale or P/S ratio amounts to 5.98. Its return on asset (ROA) is -71.37% on average.
#
